This was one of the results about which I was most apprehensive, but while I don't think the quality of the result is all that flash, at least they haven't downgraded EBITDA outlook for FY25, which implies a 10% EBITDA growth.
But I'll wager no analysts have fully accounted for the interest expense line, which is surging - $65m in DY203 and $86m in JH25, for a total of $151m for FY24, and which is expected to rise by a further 25% in FY25.
It means that operating leverage benefits will be dampened and 10% EBITDA growth will probably only be matched at the bottom line.
But still, could have been worse.
.
Ann: Preliminary Final Report, page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$27.94 |
Change
0.220(0.79%) |
Mkt cap ! $13.42B | |||
| Open | High | Low | Value | Volume |
| $27.94 | $28.22 | $27.07 | $49.02M | 1.762M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5236 | $27.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $28.00 | 84079 | 16 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| SHL (ASX) Chart |